Story perspectives

Alzheimer's: Immune Dysfunction Sparks 'Type 3 Diabetes' Debate

10/12/2025

41 3

Summary

Story summary

Recent research links Alzheimer's disease to immune dysfunction and insulin resistance, with some calling it "Type 3 Diabetes."
Beta-amyloid, once seen as harmful, may participate in the brain's immune response.
Controversies over past research integrity have emerged regarding beta-amyloid's role.
Nanoparticle-based therapies aim to restore the blood-brain barrier and improve cognition.
Alzheimer's affects over 50 million people worldwide, underscoring the need for new approaches.

1 of 1

Story summary

Recent research links Alzheimer's disease to immune dysfunction and insulin resistance, with some calling it "Type 3 Diabetes."
Beta-amyloid, once seen as harmful, may participate in the brain's immune response.
Controversies over past research integrity have emerged regarding beta-amyloid's role.
Nanoparticle-based therapies aim to restore the blood-brain barrier and improve cognition.
Alzheimer's affects over 50 million people worldwide, underscoring the need for new approaches.